Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05882734
Title M1774 in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UPMC Cancer Center NOT_YET_RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Tennessee Cancer Specialists - Biomedical Research RECRUITING Knoxville Tennessee 37909 United States Details
Millennium Research & Clinical Development RECRUITING Houston Texas 77090 United States Details
National Cancer Center Hospital RECRUITING Chuo-ku Japan Details
Kansai Medical University Hospital RECRUITING Hirakata-shi Japan Details
National Cancer Center Hospital East RECRUITING Kashiwa-shi Japan Details
Cancer Institute Hospital of JFCR RECRUITING Koto-ku Japan Details
Kurume University Hospital RECRUITING Kurume-shi Japan Details
Aichi Cancer Center Hospital RECRUITING Nagoya-shi Japan Details
Kindai University Hospital RECRUITING Osakasayama-shi Japan Details
Kanagawa Cancer Center RECRUITING Yokohama-shi Japan Details
Samsung Medical Center RECRUITING Seoul Korea, Republic of Details
Severance Hospital, Yonsei University Health System - Division of Infectious Diseases RECRUITING Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field